|
2025
|
P/S
|
Pharmaceutical preparations for use in the area of mental health care and the treatment of centra... |
|
|
P/S
|
Pharmaceutical preparations for use in the area of mental
health care and the treatment of centr... |
|
|
Invention
|
Intranasal drug delivery system. An intranasal drug delivery device for targeting primary, second... |
|
|
Invention
|
Treatment of dysmenorrhea. Methods and compositions for treating dysmenorrhea are disclosed. Incl... |
|
|
Invention
|
Treatment of dysmenorrhea.
Methods and compositions for treating dysmenorrhea are disclosed. Inc... |
|
|
Invention
|
Intranasal drug delivery system.
An intranasal drug delivery device for targeting primary, secon... |
|
2024
|
Invention
|
1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance.... |
|
|
Invention
|
Dosage forms and therapeutic uses of l-4-chlorokynurenine.
Compositions of L-4-chlorokynurenine ... |
|
2022
|
Invention
|
Therapeutic uses of l-4-chlorokynurenine.
Pharmaceutical compositions comprising L-4-chlorokynur... |
|
|
Invention
|
Dosage forms and therapeutic uses of l-4-chlorokynurenine. Compositions of L-4-chlorokynurenine a... |
|
|
Invention
|
Treatment of autoimmune anti-nmda-receptor encephalitis. Disclosed herein are methods of treating... |
|
2021
|
Invention
|
Cocrystals of l-4-chlorokynurenine, compositions and therapeutic uses thereof. Disclosed are cocr... |
|
|
P/S
|
Pharmaceuticals, namely medicines for the treatment of mental health disorders; pharmaceutical pr... |
|
|
P/S
|
Pharmaceuticals; pharmaceutical preparations for human
beings and veterinary preparations for me... |
|
|
Invention
|
Treatment of adjustment disorders.
This invention relates to methods of treating adjustment diso... |
|
|
Invention
|
Treatment of adjustment disorders. This invention relates to methods of treating adjustment disor... |
|
2020
|
Invention
|
Genetic variants associated with response to treatment of neurological disorders.
Method of trea... |
|
|
Invention
|
Genetic variants associated with response to treatment of neurological disorders. Method of treat... |
|
2019
|
Invention
|
Synthesis of 4-chlorokynurenines and intermediates. The invention relates to an overall enantio-s... |
|
2018
|
Invention
|
Dosage forms and therapeutic uses of l-4-chlorokynurenine. Compositions of L-4-chlorokynurenic ar... |
|
2017
|
Invention
|
Methods for the synthesis of chiral kynurenine compounds. Provided are methods for synthesizing c... |
|
2016
|
Invention
|
Therapeutic uses of l-4-chlorokynurenine. Pharmaceutical compositions comprising L-4-chlorokynure... |
|
|
Invention
|
Dosage forms and therapeutic uses l-4-chlorokynurenine. Compositions of L-4-chlorokynurenine are ... |
|
2014
|
Invention
|
Synthesis of chiral kynurenine compounds and intermediates.
Provided are methods for the synthes... |
|
|
Invention
|
Synthesis of chiral kynurenine compounds and intermediates. Provided are methods for the synthesi... |
|
2012
|
Invention
|
Toxicity typing using liver stem cells. This invention provides methods and systems for identifyi... |
|
2011
|
Invention
|
Induction of ips cells using transient episomal vectors. The invention provides induced pluripote... |
|
2009
|
Invention
|
Pancreatic endocrine progenitor cells derived from pluripotent stem cells.
The invention provide... |
|
|
Invention
|
Pancreatic endocrine progenitor cells derived from pluripotent stem cells. The invention provides... |
|
|
Invention
|
Pancreatic endocrine progenitor cells derived from pluripotent stem cells.
The inventi... |
|
2001
|
P/S
|
Stem cells for use in medical diagnostics and pharmaceutical development. Biotechnology services,... |
